Cetuximab plus FOLFOXIRI versus cetuximab plus FOLFOX as conversion regimen in RAS/BRAF wild-type patients with initially unresectable colorectal liver metastases (TRICE trial): A randomized controlled trial

التفاصيل البيبلوغرافية
العنوان:	Cetuximab plus FOLFOXIRI versus cetuximab plus FOLFOX as conversion regimen in RAS/BRAF wild-type patients with initially unresectable colorectal liver metastases (TRICE trial): A randomized controlled trial
المؤلفون:	De-Shen Wang, Chao Ren, Shan-Shan Li, William Pat Fong, Xiao-Jun Wu, Jian Xiao, Bin-Kui Li, Yun Zheng, Pei-Rong Ding, Gong Chen, Miao-Zhen Qiu, Zhi-Qiang Wang, Feng-Hua Wang, Hui-Yan Luo, Feng Wang, Xiao-Zhong Wang, Ling-Yun Wang, De-Jin Xie, Tao Chen, Li-Ren Li, Zhen-Hai Lu, Xiao-Hui Zhai, Tian-Shu Liu, Ying Yuan, Jia-Qi Chen, Qiong Tan, Zhi-Zhong Pan, De-Sen Wan, Rong Zhang, Yun-Fei Yuan, Rui-Hua Xu, Yu-Hong Li
المصدر:	PLoS Medicine, Vol 21, Iss 5 (2024)
بيانات النشر:	Public Library of Science (PLoS), 2024.
سنة النشر:	2024
المجموعة:	LCC:Medicine
مصطلحات موضوعية:	Medicine
نوع الوثيقة:	article
وصف الملف:	electronic resource
اللغة:	English
تدمد:	1549-1277 1549-1676
Relation:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11086847/?tool=EBI; https://doaj.org/toc/1549-1277; https://doaj.org/toc/1549-1676
URL الوصول:	https://doaj.org/article/9500492e85614129bfe3ee4489417f78
رقم الانضمام:	edsdoj.9500492e85614129bfe3ee4489417f78
قاعدة البيانات:	Directory of Open Access Journals

الوصف
تدمد:	15491277 15491676